News

Consuming a high-fat, high-sugar diet causes a harmful accumulation of fat in the liver that may not reverse even after switching to a healthier diet, according to a new study by scientists from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.

Combining radiation with an immune system-boosting therapy called ipilimumab led to regression of metastatic tumors not targeted by the radiation in lung cancer patients, according to results of an early clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

In recognition of its outstanding commitment to diversity and inclusion, Weill Cornell Medicine has been awarded INSIGHT Into Diversity magazine’s 2018 Health Professions Higher Education Excellence in Diversity (HEED) Award. INSIGHT Into Diversity is the oldest and largest diversity-focused publication in higher education.

Awards, honors, prizes and achievements for the month of October.

World experts in neurodegenerative diseases gathered at Weill Cornell Medicine Sept. 25 for the sixth annual Appel Alzheimer’s Disease Research Institute Symposium, sponsored by the Appel Institute and its home department, the Feil Family Brain and Mind Research Institute. Every year, the symposium highlights the latest discoveries in the field, as researchers work their way toward a cure.

Weill Cornell Medicine investigators Dr. David Lyden and Dr. Ari Melnick have been awarded Outstanding Investigator Awards from the National Cancer Institute.

A dynamic culture of mentorship should be raised to the level of a major strategic priority at academic medical centers to maximize their success, according to new commentary by administrators from Weill Cornell Medicine and the Association of American Medical Colleges. 

The trend toward intense exercise has triggered an increase in a potentially life-threatening condition

As therapies for HIV infection have advanced to help many patients control the infection as a chronic disease, investigators and patients have set their sights on a new goal—finding a cure.

A new lectureship honors Dr. Elizabeth Wilson-Anstey's four decades of service to the Travelers Summer Research Fellowship Program.

The second annual Dean’s Symposium on Opportunities for Entrepreneurship and Academic Drug Development highlighted the resources available to Weill Cornell Medicine investigators to help them turn their research findings into new treatments and therapies for patients.

A year in Guatemala reconnects a student physician to her love of medicine.

A new program—led by Dr. Ruth Gotian, a veteran educator and administrator—aims to promote mentorship at Weill Cornell Medicine.

Ovarian tumors disable the immune system’s killer T cells—which protect the body by destroying infected or malignant cells—enabling the disease to flourish unchecked, according to a new study by Weill Cornell Medicine scientists.

Dr. Deborah Estrin has been awarded a 2018 MacArthur Foundation fellowship for her innovative work using mobile devices and data to address social challenges.

Telemedicine is a growing field at NewYork-Presbyterian/ Weill Cornell Medical Center—and Weill Cornell Medicine is at the forefront of training future physicians in the art of the virtual exam.

Dr. Dan Landau has received a New Innovator Award from the National Institutes of Health for his research on how tumor cells evolve and acquire new mutations to evade cancer therapies.

A type of stem cell newly discovered by Weill Cornell Medicine and NewYork-Presbyterian investigators is responsible for growing and healing the hard, outer surface of bone.

Awards, honors, prizes and achievements for the month of September.

Weill Cornell Medicine has been awarded a four-year, $2.7 million grant from the Health Resources and Services Administration (HRSA) to establish a Diversity Center of Excellence dedicated to increasing the number of minority physicians in academic medicine.